ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,039.31
-0.47%
US Tech 100
20,833.20
0.00%
다우존스 지수
44,713.52
-0.31%
Bitcoin
105,222.54
1.43%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Oruka Therapeutics Inc (ORKA) 시세

Oruka Therapeutics Inc

Oruka Therapeutics Inc (ORKA)

NASDAQ
12.07
0.00
(0.00%)
마감 30 1월 6:00AM
15분 지연
0.00
0.00
(0.00%)
시간외 거래: -
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
12.07
매수가
11.84
매도가
15.00
거래량
-
0.00 일간 변동폭 0.00
10.95 52주 범위 31.13
market_cap
422.432M
전일 종가
12.07
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
310,605
발행 주식
34,998,550
배당수익률
-
주가수익률
-79.02
주당순이익(EPS)
-0.15
매출
-
순이익
-5.34M

Oruka Therapeutics Inc 정보

ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome ... ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. 더 보기

섹터
In Vitro,in Vivo Diagnostics
산업
In Vitro,in Vivo Diagnostics
웹사이트
www.orukatx.com
본부
Wilmington, Delaware, USA
설립됨
-
Oruka Therapeutics Inc is listed in the In Vitro,in Vivo Diagnostics sector of the 나스닥 with ticker ORKA. The last closing price for Oruka Therapeutics was US$12.07. Over the last year, Oruka Therapeutics shares have traded in a share price range of US$ 10.95 to US$ 31.13.

Oruka Therapeutics currently has 34,998,550 shares in issue. The market capitalisation of Oruka Therapeutics is US$422.43 million. Oruka Therapeutics has a price to earnings ratio (PE ratio) of -79.02.

ORKA 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities

25 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 1월 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 1월 2025
Edgar (US Regulatory)

Form 8-K - Current report

19 12월 2024
Edgar (US Regulatory)

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial...

19 12월 2024
GlobeNewswire Inc.

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the...

18 12월 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

27 11월 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

22 11월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

22 11월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.4-3.2076984763412.4712.88510.9520613011.8773667CS
4-7.71-38.978766430719.7821.31510.9532103314.56857166CS
12-14.21-54.071537290726.2828.0910.9531060519.37728368CS
26-16.93-58.37931034482931.1310.9520575120.82518127CS
52-16.93-58.37931034482931.1310.9520575120.82518127CS
156-16.93-58.37931034482931.1310.9520575120.82518127CS
260-16.93-58.37931034482931.1310.9520575120.82518127CS

ORKA - Frequently Asked Questions (FAQ)

What is the current Oruka Therapeutics share price?
The current share price of Oruka Therapeutics is US$ 12.07
How many Oruka Therapeutics shares are in issue?
Oruka Therapeutics has 34,998,550 shares in issue
What is the market cap of Oruka Therapeutics?
The market capitalisation of Oruka Therapeutics is USD 422.43M
What is the 1 year trading range for Oruka Therapeutics share price?
Oruka Therapeutics has traded in the range of US$ 10.95 to US$ 31.13 during the past year
What is the PE ratio of Oruka Therapeutics?
The price to earnings ratio of Oruka Therapeutics is -79.02
What is the reporting currency for Oruka Therapeutics?
Oruka Therapeutics reports financial results in USD
What is the latest annual profit for Oruka Therapeutics?
The latest annual profit of Oruka Therapeutics is USD -5.34M
What is the registered address of Oruka Therapeutics?
The registered address for Oruka Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Oruka Therapeutics website address?
The website address for Oruka Therapeutics is www.orukatx.com
Which industry sector does Oruka Therapeutics operate in?
Oruka Therapeutics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AALAmerican Airlines Group Inc
US$ 17.33
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.435
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.89
(0.00%)
0
AACGATA Creativity Global
US$ 0.8559
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.33
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.435
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.89
(0.00%)
0
AACGATA Creativity Global
US$ 0.8559
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.33
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.435
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.89
(0.00%)
0
AACGATA Creativity Global
US$ 0.8559
(0.00%)
0

토론

전체 피드 보기
Alexulf Alexulf 6 분 전
TSX announcement on Euro Sun Mining 2024 - https://www.eurosunmining.com/investors/#presentation
let`s read the what played out during the last year!
CPNFF
THDR THDR 10 분 전
EHang Soars at CCTV Spring Festival Gala: A Fusion of Technology and Cultural Heritage

This Chinese New Year, EHang made a stunning debut at the 2025 CCTV Spring Festival Gala, the world's first autonomous passenger aircraft certified with three CAAC airworthiness credentials (Type Ce
EH
Alexulf Alexulf 12 분 전
This year we can expect; Offtake agreement with Glencore: Euro Sun has signed a Memorandum of Understanding (MOU) with Glencore to sell all future concentrates from the Rovina Valley project. This agreement gives Glencore the first right to purchase future production and the opportunity to nominate
CPNFF
Alexulf Alexulf 16 분 전
The new CEO made a few major share purchases, when it bottomed last year. With this he has around 8% of the outstanding shares in his name today.
CPNFF
Alexulf Alexulf 21 분 전
So, here we are again; it`s time to take a NEW look at one of the largest and soon to be copper/gold producers within the European Union.

If all goes as planned, the summer of next year can be the start of production!

Euro Sun Mining has the potential for value apprecia
CPNFF
DocLee DocLee 28 분 전
"trivial market for cell therapy" aka a foot in the door.
NWBO
Zilidium Zilidium 31 분 전
Well I am glad to hear things are very serious, I was worried there might be some funny business going.😉
VAPR
Alexulf Alexulf 38 분 전
So, here we are again; it`s time to take a NEW look at one of the largest and soon to be copper/gold producers within the European Union.

If all go as plan, the summer of next year can be the start of production!

Euro Sun Mining has the potential for value appreciation
CPNFF
Seminole Red Seminole Red 43 분 전
The Trump administration has ended the extension of a program that provides protection for some 600,000 Venezuelan nationals living in the United States, an official said on Jan. 29.
“We are withdrawing the directive on temporary status for Venezuelans,” U.S. Department of Homeland Security (
Seminole Red Seminole Red 45 분 전
NEW: Reports being confirmed that Russian Figure Skating Champions, Evgenia Shishkova and Vadim Naumov were onboard PSA Airlines Flight 5342, when it crashed earlier tonight into the Potomac River, following a Mid-Air Collision with a Helicopter, while approaching Ronald Reagan Washington National A
Seminole Red Seminole Red 48 분 전
im working on it
big bambino big bambino 56 분 전
Can someone advise me on a situation of a stock I own. Tried speaking with Merrill and only came away more confused. I have shares in GNS @ $.56. now my portfolio shows GNSRT @$.078.

Genius Files Rights Offering to Fund Bitcoin Purchases
January 22, 2025
12:35 PM ETPubli
GNS
Explosivo Explosivo 56 분 전
This stock and stocks in general like this just suck the life out of you. It’s a real helpless feeling. You can’t do anything to change what it might do and all you are left with is the hope that the stewards of the thing will actually do what they say they will. It’s painful, it’s frustrating, and
HMBL
Horseb4CarT Horseb4CarT 57 분 전
And yet, it is time for approval. 

If not today, real soon. 
NWBO
wagner wagner 58 분 전
https://en.m.wikipedia.org/wiki/Cesar_Conda
NB
pegs1 pegs1 1 시간 전
Test 🕵️
Thanks for the info!
CRTG
lovethatgreen lovethatgreen 1 시간 전
Actually Marshall says a partner o another company he co founded has recieved a p1 project from a major defense contractor and will move to a phase 2 in Jan. He talks about the venture arm funding but its n o t clear who gets what exactly. The partner or moni or shieldcom or all 3. He never mentio
MONI
Killmaril Killmaril 1 시간 전
Manipulation here.. It´s done. Trumpet don´t like China. Ai manipulation with price... And many other stock...It sad..
TANH
jeunke22 jeunke22 1 시간 전
https://www.linkedin.com/posts/cesarconda_pentagon-nationalsecurity-foreignpolicy-activity-7290508326080040960-U9h3?utm_source=share&utm_medium=member_android
NB
Plato_ Plato_ 2 시간 전
Greetings, iamadog! You make great points. Thank you for them. I would like to expand on longevity and no dilution. VeeMost was founded in 2002 according to its https://veemost.com/about-veemost/ website . So, its longevity to date is about 23 years. VeeMost has been a public company for 2 years.
GDVM
gdl gdl 2 시간 전
Middle of a despot's total control of this country and you only see profits. Like a pandemic declared and everyone ignored it. NO ONE can ever argue the facts on Trump, can they. they might approve or think it benefits them BUT not that he is a MONSTER.

Trump has 2 years to fix the
SPY

최근 히스토리

NASDAQ
ORKA
Oruka Therapeutics
ASE
REVOIL
Revoil Petrol R
FX
USDEGP
US Dollar vs EGP
TG
FTK
Flatex
NASDAQ
IROQ
IF Bancorp
LBNK
IDUSDT
Space ID
NYSE
MC
Moelis
AQSE
GWMO.GB
Great Western Mining
LSE
PI01
Bp Cap B.v. 31
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지